A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

ClinicalTrials.gov ID: NCT07038200

Public ClinicalTrials.gov record NCT07038200. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 22, 2026, 9:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)

Study identification

NCT ID: NCT07038200
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Avidity Biosciences, Inc.; Industry
Enrollment: 200 participants

Conditions and interventions

Conditions

Interventions

AOC-1020 Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 16 Years to 70 Years
Sex: All
Healthy volunteers: Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 9, 2025
Primary completion: Apr 30, 2028
Completion: Jun 30, 2028
Last update posted: Jan 19, 2026

2025 – 2028

United States locations

U.S. sites: 14
U.S. states: 13
U.S. cities: 14

Facility	City	State	ZIP	Site status
University of California Irvine	Orange	California	92868	Recruiting
Stanford University	Palo Alto	California	94304	Recruiting
University of Colorado	Denver	Colorado	80045	Recruiting
University of Florida	Gainesville	Florida	32608	Recruiting
University of Iowa	Iowa City	Iowa	52242	Recruiting
Kansas University Medical Center	Kansas City	Kansas	66205	Recruiting
Kennedy Krieger Institute	Baltimore	Maryland	21205	Recruiting
University of Massachusetts	Worcester	Massachusetts	01655	Recruiting
University of Rochester Medical Center	Rochester	New York	14642	Recruiting
Duke University	Durham	North Carolina	27708	Recruiting
Ohio State University	Columbus	Ohio	43221	Recruiting
University of Pennsylvania	Philadelphia	Pennsylvania	19104	Recruiting
University of Texas Health Science Center at San Antonio	San Antonio	Texas	78229	Recruiting
Virginia Commonwealth University	Richmond	Virginia	23298	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07038200, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 19, 2026 · Synced Apr 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07038200 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →